Insulet (PODD) Gross Profit Growth (3y) (2013 - 2026)
Insulet (PODD) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 9.77% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 12.24% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 14.82% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 9.36% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 14.95% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 3.96% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.99% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 8.95% |
| 10 | Insulet | 10.31 Bn | 9.77 Bn | 562.60 Mn | 28.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.54% |
| Mar 31, 2026 | 30.06% |
| Dec 31, 2025 | 37.80% |
| Sep 30, 2025 | 39.40% |
| Jun 30, 2025 | 33.44% |
| Mar 31, 2025 | 24.94% |
| Dec 31, 2024 | 26.43% |
| Sep 30, 2024 | 25.96% |
| Jun 30, 2024 | 21.90% |
| Mar 31, 2024 | 22.35% |
| Dec 31, 2023 | 30.88% |
| Sep 30, 2023 | 24.55% |
| Jun 30, 2023 | 22.96% |
| Mar 31, 2023 | 23.75% |
| Dec 31, 2022 | 17.46% |
| Sep 30, 2022 | 15.22% |
| Jun 30, 2022 | 17.80% |
| Mar 31, 2022 | 25.26% |
| Dec 31, 2021 | 24.57% |
| Sep 30, 2021 | 22.76% |